Display options
Cite
Dorella FA, Gala-Garcia A, Pinto AC, et al. Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience. Comput Struct Biotechnol J. 2013;6:e201303013doi: 10.5936/csbj.201303013.
Dorella, F. A., Gala-Garcia, A., Pinto, A. C., Sarrouh, B., Antunes, C. A., Ribeiro, D., Aburjaile, F. F., Fiaux, K. K., Guimarães, L. C., Seyffert, N., El-Aouar, R. A., Silva, R., Hassan, S. S., Castro, T. L., Marques, W. S., Ramos, R., Carneiro, A., de Sá, P., Miyoshi, A., Azevedo, V., & Silva, A. (2013). Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience. Computational and structural biotechnology journal, 6e201303013. https://doi.org/10.5936/csbj.201303013
Dorella, Fernanda A, et al. "Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience." Computational and structural biotechnology journal vol. 6 (2013): e201303013. doi: https://doi.org/10.5936/csbj.201303013
Dorella FA, Gala-Garcia A, Pinto AC, Sarrouh B, Antunes CA, Ribeiro D, Aburjaile FF, Fiaux KK, Guimarães LC, Seyffert N, El-Aouar RA, Silva R, Hassan SS, Castro TL, Marques WS, Ramos R, Carneiro A, de Sá P, Miyoshi A, Azevedo V, Silva A. Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience. Comput Struct Biotechnol J. 2013 Oct 13;6:e201303013. doi: 10.5936/csbj.201303013. eCollection 2013. PMID: 24688721; PMCID: PMC3962224.
Copy Download .nbib Format: NLM
Share it on

Comput Struct Biotechnol J. 2013 Oct 13;6:e201303013. doi: 10.5936/csbj.201303013. eCollection 2013.

Progression of 'OMICS' methodologies for understanding the pathogenicity of Corynebacterium pseudotuberculosis: the Brazilian experience.

Computational and structural biotechnology journal

Fernanda A Dorella, Alfonso Gala-Garcia, Anne C Pinto, Boutros Sarrouh, Camila A Antunes, Dayana Ribeiro, Flavia F Aburjaile, Karina K Fiaux, Luis C Guimarães, Núbia Seyffert, Rachid A El-Aouar, Renata Silva, Syed S Hassan, Thiago L P Castro, Wanderson S Marques, Rommel Ramos, Adriana Carneiro, Pablo de Sá, Anderson Miyoshi, Vasco Azevedo, Artur Silva

Affiliations

  1. Laboratório de Genética Celular e Molecular, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais, Brazil.
  2. Instituto de Ciências Biológicas, Universidade Federal do Pará, Belém-PA, Brazil.

PMID: 24688721 PMCID: PMC3962224 DOI: 10.5936/csbj.201303013

Abstract

Since the first successful attempt at sequencing the Corynebacterium pseudotuberculosis genome, large amounts of genomic, transcriptomic and proteomic data have been generated. C. pseudotuberculosis is an interesting bacterium due to its great zoonotic potential and because it causes considerable economic losses worldwide. Furthermore, different strains of C. pseudotuberculosis are capable of causing various diseases in different hosts. Currently, we seek information about the phylogenetic relationships between different strains of C. pseudotuberculosis isolates from different hosts across the world and to employ these data to develop tools to diagnose and eradicate the diseases these strains cause. In this review, we present the latest findings on C. pseudotuberculosis that have been obtained with the most advanced techniques for sequencing and genomic organization. We also discuss the development of in silico tools for processing these data to prompt a better understanding of this pathogen.

Keywords: Corynebacterium pseudotuberculosis; Ion Torrent next generation sequencing; RNA-seq; SDS-PAGE; SOLiD next generation sequencing; mass spectrometry

References

  1. Vet Immunol Immunopathol. 2003 Dec 15;96(3-4):129-39 - PubMed
  2. BMC Genomics. 2011 Dec 22;12 Suppl 4:S11 - PubMed
  3. Int J Med Microbiol. 2011 Dec;301(8):619-22 - PubMed
  4. Nat Rev Genet. 2010 Jan;11(1):9-16 - PubMed
  5. PLoS One. 2011 Apr 18;6(4):e18551 - PubMed
  6. Proteomics. 2002 May;2(5):580-90 - PubMed
  7. Protein Expr Purif. 2004 Apr;34(2):311-6 - PubMed
  8. Scand J Immunol. 2012 Apr;75(4):369-78 - PubMed
  9. Infect Immun. 1994 Jun;62(6):2562-7 - PubMed
  10. Microbiology (Reading). 2007 Jul;153(Pt 7):2203-2211 - PubMed
  11. Microb Biotechnol. 2013 Mar;6(2):150-6 - PubMed
  12. Vet Res. 2006 Mar-Apr;37(2):201-18 - PubMed
  13. Genet Mol Res. 2006 Nov 30;5(4):653-63 - PubMed
  14. Vet Microbiol. 1993 Dec;38(1-2):59-70 - PubMed
  15. J Proteome Res. 2011 Apr 1;10(4):2064-78 - PubMed
  16. Vet Microbiol. 1992 Jan;30(1):47-58 - PubMed
  17. Proteomics. 2005 Apr;5(6):1544-57 - PubMed
  18. BMC Microbiol. 2011 Jan 17;11(1):12 - PubMed
  19. Biol Direct. 2012 Jan 10;7:2 - PubMed
  20. Chem Biol Drug Des. 2011 Jul;78(1):73-84 - PubMed
  21. PLoS One. 2012;7(2):e30848 - PubMed
  22. BMC Res Notes. 2011 Apr 18;4:130 - PubMed
  23. J Biotechnol. 2003 Sep 4;104(1-3):41-53 - PubMed
  24. BMC Genomics. 2012;13 Suppl 5:S6 - PubMed
  25. Expert Rev Vaccines. 2009 Feb;8(2):205-13 - PubMed
  26. Microbiol Mol Biol Rev. 1998 Jun;62(2):379-433 - PubMed
  27. J Appl Microbiol. 2000 Apr;88(4):669-77 - PubMed
  28. Microbiol Mol Biol Rev. 2006 Sep;70(3):755-88 - PubMed
  29. Proteomics. 2011 Aug;11(15):3190-202 - PubMed
  30. J Proteomics. 2009 Jul 21;72(5):815-21 - PubMed
  31. Bioinformation. 2012;8(11):529-31 - PubMed
  32. Protein Cell. 2012 May;3(5):346-63 - PubMed
  33. Microb Biotechnol. 2013 Mar;6(2):168-77 - PubMed
  34. FEMS Microbiol Lett. 2002 Feb 19;208(1):41-5 - PubMed
  35. Integr Biol (Camb). 2012 Jul;4(7):789-94 - PubMed
  36. Infect Immun. 2010 Sep;78(9):3957-68 - PubMed
  37. J Microbiol Methods. 2011 Aug;86(2):218-23 - PubMed
  38. Curr Opin Chem Biol. 2008 Feb;12(1):93-101 - PubMed

Publication Types